Welcome to our dedicated page for ISPIRE TECHNOLOGY news (Ticker: ISPR), a resource for investors and traders seeking the latest updates and insights on ISPIRE TECHNOLOGY stock.
Ispire Technology Inc. (NASDAQ: ISPR) generates a steady flow of news centered on vaping technology, precision dosing and regulatory engagement across nicotine and cannabis markets. As a tobacco manufacturing company focused on e‑cigarettes and cannabis vaping hardware, its announcements often highlight product launches, manufacturing milestones and developments in age‑verification technology.
Company news frequently covers the evolution of its Aspire and Ispire product lines, including detailed hardware ecosystems for cannabis brands and structured device architectures unveiled at major industry events such as MJBizCon. These updates describe new series of devices designed for different formulations, performance requirements and use cases, reflecting Ispire’s emphasis on hardware engineering and ODM partnerships.
Ispire’s press releases also address regulatory and compliance themes. The company and its joint venture IKE Tech LLC report on progress with FDA submissions, including a component Pre‑Market Tobacco Product Application (PMTA) for a blockchain‑enabled age‑verification chip, as well as responses to policy actions targeting illicit vape markets and youth access. Additional coverage includes conference participation in nicotine delivery and cannabis capital events, where company executives discuss harm reduction, identity verification and market trends within regulated ENDS and cannabis hardware sectors.
Operational updates, such as the interim nicotine manufacturing license in Malaysia and statements from Ispire Malaysia about export‑only manufacturing and regulatory compliance, provide further context on the company’s manufacturing footprint and strategic initiatives. Investors, analysts and industry participants can use this news feed to follow Ispire’s product roadmap, regulatory interactions, manufacturing expansion and joint‑venture activities. Bookmark this page to monitor ongoing announcements, event participation and technology disclosures related to ISPR.
Ispire Technology (NASDAQ: ISPR) reported fiscal Q2 2026 results for the quarter ended December 31, 2025, showing revenue of $20.3M (versus $41.8M prior year) and a net loss of $6.6M ($0.12 per share). Cash totaled $17.6M and working capital was $3.5M.
The company said gross profit was $3.5M (17.1% margin) and operating expenses declined to $10.3M as AR fell 19.5% to $37.9M, reflecting a shift to higher-quality customers and cost controls.
Ispire (NASDAQ: ISPR) said IKE Tech, a joint venture with Ispire as a founding partner, was invited to an FDA Roundtable on PMTA submissions on February 10, 2026. The invitation, limited to 30 companies, recognizes IKE Tech as a stakeholder and the role of point-of-use age-gating technology. IKE will join the Manufacturing Controls panel and has submitted the first-ever component PMTA for an interoperable, blockchain-enabled Bluetooth age-verification system.
The company framed the engagement as a chance to inform PMTA guidance and advance regulatory-ready, youth-protective technical controls for ENDS products.
WM Technology (Nasdaq: MAPS) appointed Harry DeMott and Brent Cox to its Board of Directors effective February 1, 2026, and confirmed Susan Echard will transition from a contracted CFO role to full employment effective January 30, 2026. The additions emphasize cannabis industry, technology, and capital markets experience.
The company said the new directors bring board and operating experience to support Weedmaps marketplace and the firm's growth in the evolving cannabis sector.
Ispire Technology (NASDAQ: ISPR) will hold its fiscal second quarter 2026 earnings conference call at 8:00 am ET on Friday, February 6, 2026 to discuss results for the quarter ended December 31, 2025. The call is available by dial-in or live webcast.
Dial-in numbers include US 877-451-6152 and International +1 201-389-0879. The webcast link is provided for registration; attendees should access it at least fifteen minutes early. A playback replay will be available through 11:59 pm ET on February 20, 2026 with passcode 13758138.
Credit Acceptance (Nasdaq: CACC) announced an amendment extending its $100.0 million asset-backed non-recourse secured financing (Term ABS 2021-1). The financing's revolve stop date was extended from February 17, 2026 to January 18, 2028. The borrowing spread was reduced from SOFR + 220 bps to SOFR + 140 bps, with no other material term changes.
The company reiterated its business description and provided investor contact details.
Ispire Technology (NASDAQ: ISPR) will unveil a fully reengineered cannabis hardware ecosystem at MJBizCon 2025, Dec 2–5 at the Las Vegas Convention Center. The launch introduces three product families—E-Series (Essentials), S-Series (Specialized) and C-Series (Custom/ODM)—with devices designed for varied oil viscosities, activation types (draw/button/dual) and global compliance. Key models include compact draw-activated and high-viscosity units, flagship dual-activation devices, and fully custom ODM options. Senior executives, including VP of Sales John Monds, will be available for on-site meetings; scheduling via john.monds@getispire.com.
Ispire Technology (NASDAQ: ISPR) and IKE Tech responded to the U.S. Food and Drug Administration's new enforcement direction under the Nov. 17, 2025 continuing resolution that requires the FDA to allocate at least $200 million of its $712 million in user fees to ENDS enforcement and to fund a multi-agency task force with $2 million for removing illegal imports.
Both companies promoted their blockchain-enabled, FDA-submitted System-on-a-Chip and age-verification solutions as technology to enable real-time product tracing, device-level identity validation, and interoperability to curb illicit disposable vapes and protect youth in the $30 billion flavored vape market.
Ispire Technology (NASDAQ: ISPR) will host its fiscal first quarter 2026 earnings conference call at 8:00 am ET on Thursday, November 6, 2025 to discuss results for the quarter ended September 30, 2025.
Dial-in numbers: US 844-826-3033 or International +1 412-317-5185; ask for the "Ispire Technology Call." The call will be webcast live at https://viavid.webcasts.com/starthere.jsp?ei=1738889&tp_key=82f919c8ba (register 15 minutes early to install audio software).
A replay will be available through midnight ET on Thursday, November 20, 2025 via dial 844-512-2921 or +1 412-317-6671 using passcode 10203874.
Ispire Technology Inc. (NASDAQ: ISPR) reported challenging financial results for fiscal year 2025, with revenue declining to $127.5 million from $151.9 million in FY2024. The company's strategic shift from cannabis to nicotine sectors led to decreased gross profit of $22.6 million and widened net loss to $39.2 million.
Key developments include progress in PMTA activities through IKE Tech LLC joint venture, featuring blockchain-based age verification technology. The company reported $18M in backlog orders entering Q1 2026 and implemented cost-cutting measures resulting in $10.2 million in annual payroll savings. As of June 30, 2025, Ispire maintained $24.4 million in cash and cash equivalents with working capital of $0.4 million.
Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has scheduled its fiscal fourth quarter and full year 2025 earnings conference call for September 16, 2025, at 8:00 AM ET.
The call will discuss financial results for the period ended June 30, 2025. Investors can access the call through North American toll-free number (877-451-6152) or International number (+1 201-389-0879). A live webcast will be available, and a replay will be accessible until September 30, 2025, using passcode 13755309.
FAQ
What is the current stock price of ISPIRE TECHNOLOGY (ISPR)?
What is the market cap of ISPIRE TECHNOLOGY (ISPR)?
